StockData
Maze Therapeutics, Inc. logo

Maze Therapeutics, Inc. (MAZE) stock

MAZENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$31.20−1.67 (-5.08%)

Close on Nov 18, 2026Market cap $1.73BP/E –Yield –

Maze Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Maze Therapeutics's price to book ratio was 4.5× on Nov 11, 2026, against 4.8× a year earlier.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20264.5×−0.8
2025Dec 31, 20255.2×–

More Maze Therapeutics figures

See a number that looks wrong?